Ophthalmology Times » Retina
2 FOLLOWERS
Ophthalmology Times is a reputable source of news and insights in the field of ophthalmology. Their website includes a dedicated section for retinal articles, covering the latest developments, research findings, and clinical updates. Stay up to date with the latest in retinal care by visiting their website and accessing their retinal section.
Ophthalmology Times » Retina
2h ago
The report details the results of preclinical discovery, engineering and characterization studies evaluating the safety, retinal cell transduction, transgene expression and clinical activity of proprietary evolved intravitreal vector R100 and 4D-150 ..read more
Ophthalmology Times » Retina
2h ago
Investigators conducted a retrospective clinical audit to determine why patients do not adhere to the guidelines among about 9,000 patients in a practice ..read more
Ophthalmology Times » Retina
2h ago
A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect anatomical or functional outcomes after epiretinal membrane surgery ..read more
Ophthalmology Times » Retina
2h ago
A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect anatomical or functional outcomes after epiretinal membrane surgery ..read more
Ophthalmology Times » Retina
2h ago
Look back on some of the top stories on Modern Retina from 2024 as we gear up for an incredible 2025 ..read more
Ophthalmology Times » Retina
2h ago
Trending topics and milestone stories from our year in ophthalmology ..read more
Ophthalmology Times » Retina
2h ago
The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been associated with cardiorespiratory and gastrointestinal adverse events ..read more
Ophthalmology Times » Retina
1M ago
USC is leading a research team aiming to better understand retinitis pigmentosa and inform future treatments ..read more
Ophthalmology Times » Retina
1M ago
In the LIGHTHOUSE study, Atsena Therapeutics is evaluating ATSN-201 gene therapy for X-linked retinoschisis, leveraging AAV.SPR capsid for central retina transduction without foveal detachment risks ..read more